JP2019026643A
|
|
Vancomycin suspension-filled capsule preparation
|
JP2008281539A
|
|
Solid agent type indicator for determining effective concentration of aldehyde-based disinfectant
|
JP2007161694A
|
|
Stabilized oral composition containing benzimidazole-based compound
|
JP2002048780A
|
|
Indicator for glutaric aldehyde concentration
|
JPH11292769A
|
|
Hyperpotassemia-improving agent composition
|
JPS63109865A
|
|
Pullulan film preparation containing drug as effective component
|
JPS57106627A
|
|
Stabilized pharmaceutical preparation containing ubiquinone
|
JPS56139423A
|
|
Hemostatic agent for dental oral use
|
JPS56136503A
|
|
Tooth brush
|
JPS56122332A
|
|
Gefarnate clathrate compound and medicinal composition containing the same
|
JPS55163005A
|
|
Toothhbrush
|
JPS55108888A
|
|
N-lysyl-d-glucosamine homolog
|
JPS5535015A
|
|
Composition for prevention of dental caries and for inhibition of progress of dental caries
|
JPS5476565A
|
|
Dicarboxylic acid monoazulenamide derivative
|
JPS5475192A
|
|
Tooth disease and proceeds suppressor composition
|
JPS53118528A
|
|
Composition for protecting tooth corrosion and controlling tooth corrosion advance
|
JPS5377043A
|
|
Derivative of azulenyl aminoglyoxylate
|
JPS5377044A
|
|
Derivative of dialkylaminoalkylamido azulenylglyoxylic acid
|
JPS52153952A
|
|
Azrenylazobenzene sulphonamide derivatives
|
JPS52153979A
|
|
Azleneoxalylpyreidine derivatiles
|